Cargando…

Sitagliptin Reduces Endothelial Dysfunction and Apoptosis Induced by High-Fat Diet and Palmitate in Thoracic Aortas and Endothelial Cells via ROS-ER Stress-CHOP Pathway

Macrovascular disease is tightly associated with obesity-induced metabolic syndrome. Sitagliptin (SIT), an orally stable selective inhibitor of Dipeptidyl peptidase-4 (DPP-4), has protective effects on endothelium. However, the mechanisms enabling SIT to exhibit resistance to diet-induced obesity (D...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Qiongqiong, Xu, Dongmei, Chen, Yong, Long, Yueming, Dai, Fang, Gui, Li, Lu, Yunxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438525/
https://www.ncbi.nlm.nih.gov/pubmed/34531738
http://dx.doi.org/10.3389/fphar.2021.670389
_version_ 1783752364221530112
author Cao, Qiongqiong
Xu, Dongmei
Chen, Yong
Long, Yueming
Dai, Fang
Gui, Li
Lu, Yunxia
author_facet Cao, Qiongqiong
Xu, Dongmei
Chen, Yong
Long, Yueming
Dai, Fang
Gui, Li
Lu, Yunxia
author_sort Cao, Qiongqiong
collection PubMed
description Macrovascular disease is tightly associated with obesity-induced metabolic syndrome. Sitagliptin (SIT), an orally stable selective inhibitor of Dipeptidyl peptidase-4 (DPP-4), has protective effects on endothelium. However, the mechanisms enabling SIT to exhibit resistance to diet-induced obesity (DIO) related with reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress in the aorta and endothelial cells have not been reported yet. Therefore, the present study was conducted to determine if SIT exerts protective role in the thoracic aortas isolated from the high-fat diet (HFD)-treated rats and palmitate (PA)-treated endothelial cells by alleviating ROS and ER stress. Male Sprague Dawley rats were randomly divided into standard chow diet (SCD), HFD and HFD plus sitagliptin administration (HFD + SIT) groups. The rats of latter two groups were given HFD fodder for 12 weeks, then the HFD + SIT rats were treated with SIT (10 mg/kg/d) by intragastric administration for another 8 weeks. The body mass, vascular tension, serum oxidative stress indices and inflammatory parameters, pathological changes, protein expression of endothelial nitric oxide synthase (eNOS), the genes associated with ER stress and apoptosis in the thoracic aorta were measured. Furthermore, cell proliferation, ROS and the protein expression associated with ER stress (especially CHOP) and apoptosis were assessed in human umbilical vein endothelial cells (HUVECs) incubated with SIT and PA. Compared to the SCD rats, the HFD rats had higher serum lipid levels, decreased vascular tension, increased inflammation, oxidative and ER stress, and apoptosis of endothelial cells. PA promoted ROS generation, ER stress and apoptosis, inhibited cell proliferation in HUVECs. SIT treatment obviously ameliorated apoptosis via alleviating ROS and ER stress in the thoracic aortas isolated from HFD-fed rats and PA-treated HUVECs. The results suggest that SIT improved endothelial function via promoting cell proliferation and alleviating ROS-ER stress-CHOP pathway both in vivo and in vitro.
format Online
Article
Text
id pubmed-8438525
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84385252021-09-15 Sitagliptin Reduces Endothelial Dysfunction and Apoptosis Induced by High-Fat Diet and Palmitate in Thoracic Aortas and Endothelial Cells via ROS-ER Stress-CHOP Pathway Cao, Qiongqiong Xu, Dongmei Chen, Yong Long, Yueming Dai, Fang Gui, Li Lu, Yunxia Front Pharmacol Pharmacology Macrovascular disease is tightly associated with obesity-induced metabolic syndrome. Sitagliptin (SIT), an orally stable selective inhibitor of Dipeptidyl peptidase-4 (DPP-4), has protective effects on endothelium. However, the mechanisms enabling SIT to exhibit resistance to diet-induced obesity (DIO) related with reactive oxygen species (ROS) and endoplasmic reticulum (ER) stress in the aorta and endothelial cells have not been reported yet. Therefore, the present study was conducted to determine if SIT exerts protective role in the thoracic aortas isolated from the high-fat diet (HFD)-treated rats and palmitate (PA)-treated endothelial cells by alleviating ROS and ER stress. Male Sprague Dawley rats were randomly divided into standard chow diet (SCD), HFD and HFD plus sitagliptin administration (HFD + SIT) groups. The rats of latter two groups were given HFD fodder for 12 weeks, then the HFD + SIT rats were treated with SIT (10 mg/kg/d) by intragastric administration for another 8 weeks. The body mass, vascular tension, serum oxidative stress indices and inflammatory parameters, pathological changes, protein expression of endothelial nitric oxide synthase (eNOS), the genes associated with ER stress and apoptosis in the thoracic aorta were measured. Furthermore, cell proliferation, ROS and the protein expression associated with ER stress (especially CHOP) and apoptosis were assessed in human umbilical vein endothelial cells (HUVECs) incubated with SIT and PA. Compared to the SCD rats, the HFD rats had higher serum lipid levels, decreased vascular tension, increased inflammation, oxidative and ER stress, and apoptosis of endothelial cells. PA promoted ROS generation, ER stress and apoptosis, inhibited cell proliferation in HUVECs. SIT treatment obviously ameliorated apoptosis via alleviating ROS and ER stress in the thoracic aortas isolated from HFD-fed rats and PA-treated HUVECs. The results suggest that SIT improved endothelial function via promoting cell proliferation and alleviating ROS-ER stress-CHOP pathway both in vivo and in vitro. Frontiers Media S.A. 2021-08-31 /pmc/articles/PMC8438525/ /pubmed/34531738 http://dx.doi.org/10.3389/fphar.2021.670389 Text en Copyright © 2021 Cao, Xu, Chen, Long, Dai, Gui and Lu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Cao, Qiongqiong
Xu, Dongmei
Chen, Yong
Long, Yueming
Dai, Fang
Gui, Li
Lu, Yunxia
Sitagliptin Reduces Endothelial Dysfunction and Apoptosis Induced by High-Fat Diet and Palmitate in Thoracic Aortas and Endothelial Cells via ROS-ER Stress-CHOP Pathway
title Sitagliptin Reduces Endothelial Dysfunction and Apoptosis Induced by High-Fat Diet and Palmitate in Thoracic Aortas and Endothelial Cells via ROS-ER Stress-CHOP Pathway
title_full Sitagliptin Reduces Endothelial Dysfunction and Apoptosis Induced by High-Fat Diet and Palmitate in Thoracic Aortas and Endothelial Cells via ROS-ER Stress-CHOP Pathway
title_fullStr Sitagliptin Reduces Endothelial Dysfunction and Apoptosis Induced by High-Fat Diet and Palmitate in Thoracic Aortas and Endothelial Cells via ROS-ER Stress-CHOP Pathway
title_full_unstemmed Sitagliptin Reduces Endothelial Dysfunction and Apoptosis Induced by High-Fat Diet and Palmitate in Thoracic Aortas and Endothelial Cells via ROS-ER Stress-CHOP Pathway
title_short Sitagliptin Reduces Endothelial Dysfunction and Apoptosis Induced by High-Fat Diet and Palmitate in Thoracic Aortas and Endothelial Cells via ROS-ER Stress-CHOP Pathway
title_sort sitagliptin reduces endothelial dysfunction and apoptosis induced by high-fat diet and palmitate in thoracic aortas and endothelial cells via ros-er stress-chop pathway
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438525/
https://www.ncbi.nlm.nih.gov/pubmed/34531738
http://dx.doi.org/10.3389/fphar.2021.670389
work_keys_str_mv AT caoqiongqiong sitagliptinreducesendothelialdysfunctionandapoptosisinducedbyhighfatdietandpalmitateinthoracicaortasandendothelialcellsviaroserstresschoppathway
AT xudongmei sitagliptinreducesendothelialdysfunctionandapoptosisinducedbyhighfatdietandpalmitateinthoracicaortasandendothelialcellsviaroserstresschoppathway
AT chenyong sitagliptinreducesendothelialdysfunctionandapoptosisinducedbyhighfatdietandpalmitateinthoracicaortasandendothelialcellsviaroserstresschoppathway
AT longyueming sitagliptinreducesendothelialdysfunctionandapoptosisinducedbyhighfatdietandpalmitateinthoracicaortasandendothelialcellsviaroserstresschoppathway
AT daifang sitagliptinreducesendothelialdysfunctionandapoptosisinducedbyhighfatdietandpalmitateinthoracicaortasandendothelialcellsviaroserstresschoppathway
AT guili sitagliptinreducesendothelialdysfunctionandapoptosisinducedbyhighfatdietandpalmitateinthoracicaortasandendothelialcellsviaroserstresschoppathway
AT luyunxia sitagliptinreducesendothelialdysfunctionandapoptosisinducedbyhighfatdietandpalmitateinthoracicaortasandendothelialcellsviaroserstresschoppathway